Eniko Barczi
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes.
Journal: BMC infectious diseases
Published: November 27, 2024
Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease.
Journal: Inflammopharmacology
Published: March 01, 2023
Fatigue, sleepiness and sleep quality are SARS-CoV-2 variant independent in patients with long COVID symptoms.
Journal: Inflammopharmacology
Published: February 28, 2023
Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment.
Journal: Journal of global health
Published: August 30, 2022
Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry.
Journal: Biomedicines
Published: June 30, 2022
Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
Journal: Immunity, inflammation and disease
Published: January 17, 2022
Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox.
Journal: Biomedicines
Published: December 31, 2021
Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline.
Journal: Frontiers in pharmacology
Published: September 17, 2021
Testicular Cancer in a Lung Transplant Patient With Cystic Fibrosis: A Case Report.
Journal: Transplantation proceedings
Published: May 19, 2019
Long-Term Effects and Adverse Events of Nintedanib Therapy in Idiopathic Pulmonary Fibrosis Patients with Functionally Advanced Disease.
Journal: Advances in therapy
Published: October 10, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026